Kenvue Declares Quarterly Cash Dividend
Dermal Mycosis Market Research Report 2025-2026 & 2035, Competitive Analysis of Bayer, Kenvue, Karo Healthcare, Novartis, Glenmark Pharmaceuticals, Sun Pharma, Teva, and Sandoz [Yahoo! Finance]
Why Kenvue Inc. (KVUE) is One of the Best Cheap Stocks to Buy Under $20 [Yahoo! Finance]
Kenvue to Announce First Quarter 2026 Results on May 7, 2026
Kenvue (KVUE) had its price target lowered by Citigroup Inc. from $20.00 to $19.00. They now have a "neutral" rating on the stock.